4//SEC Filing
Johnson Charles A 4
Accession 0001181431-11-006322
CIK 0001040416other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 4:33 PM ET
Size
5.9 KB
Accession
0001181431-11-006322
Insider Transaction Report
Form 4
Johnson Charles A
EVP of R&D & Chief Med. Ofcr.
Transactions
- Award
Restricted Stock Units
2011-01-28+27,524→ 27,524 total→ Common Stock (27,524 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the common stock of Inspire Pharmaceuticals, Inc. The shares will be delivered following the end of the scheduled vesting date or 60 days following an earlier vesting date that occurs as a result of the grantee's separation from service.
- [F2]Shall vest as follows: 25% on June 1, 2012; 25% on June 1, 2013; 25% on June 1, 2014 and 25% on June 1, 2015.
Documents
Issuer
INSPIRE PHARMACEUTICALS INC
CIK 0001040416
Entity typeother
Related Parties
1- filerCIK 0001500743
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 4:33 PM ET
- Size
- 5.9 KB